fda ruling glp 1 to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads GLP-1 Medications – FDA Guidance

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

2023 Nov 30;21(4):758-768

In a notable phase II clinical trial published in The Lancet (2008), Tesofensine demonstrated dose-dependent weight loss of up to 10.6% over 24 weeks in obese individualssubstantially higher than placebo or many existing weight-loss drugs

However, if your insurance covers weight loss injections, we can prescribe them, and you may obtain them from your pharmacy

A 15-year follow-up study published in the Bulletin of Experimental Biology and Medicine (Khavinson et al., 2011) examined the geroprotective properties of pineal-derived peptides, with findings supporting long-term benefits on aging trajectory